Product Name :
Evogliptin
CAS No.:
1222102-29-5
Purity :
Shipping:
Room temperature in the continental U.S. Other areas may vary.
Storage :
Please store the product under the recommended conditions in the Certificate of Analysis.
SMILES:
O=C1NCCN(C(C[C@H](N)CC2=CC(F)=C(F)C=C2F)=O)[C@@H]1COC(C)(C)C
Product Description :
Evogliptin (DA-1229) is an orally active DPP4 inhibitor with significant and sustained hypoglycaemic effects in mouse models.{{1374663-29-2} MedChemExpress|{1374663-29-2} Protocol|{1374663-29-2} Data Sheet|{1374663-29-2} supplier} Evogliptin also inhibits the production of inflammatory and fibrotic signals in hepatocytes by inducing autophagy. Evogliptin can be used in studies of type 2 diabetes, osteoporosis, renal impairment and chronic liver inflammation.
Formula:
C19H26F3N3O3
Molecular Weight :
401.42
Synonyms:
DA-1229
Additional Information:
|CAS No. 1222102-29-5 ; |Synonyms DA-1229 ; |Formula C19H26F3N3O3 ; |Molecular Weight 401.42 ; |SMILES O=C1NCCN(C(C[C@H](N)CC2=CC(F)=C(F)C=C2F)=O)[C@@H]1COC(C)(C)C ; |Target Dipeptidyl Peptidase, Autophagy ; |Product Description Evogliptin (DA-1229) is an orally active DPP4 inhibitor with significant and sustained hypoglycaemic effects in mouse models.{{2349294-95-5} site|{2349294-95-5} Biological Activity|{2349294-95-5} In stock|{2349294-95-5} custom synthesis} Evogliptin also inhibits the production of inflammatory and fibrotic signals in hepatocytes by inducing autophagy.PMID:31424764 Evogliptin can be used in studies of type 2 diabetes, osteoporosis, renal impairment and chronic liver inflammation. ; |Shipping Room temperature in the continental U.S. Other areas may vary. ; |Storage Please store the product under the recommended conditions in the Certificate of Analysis.
